Next Generation Humanized Mice in Preclinical Immuno-Oncology | Part II
Next-generation humanized mouse models allow immuno-oncology researchers to study novel therapeutics in the context of a more fully-functional immune system, improving the speed and translatability of their research.
Next-Generation Humanized Mice in Immuno-Oncology
Join Taconic Biosciences for the second part of our exclusive, two-part webinar series on the exciting applications for advanced humanized mouse models in preclinical immuno-oncology research.
Part I
The first session in this series explores applications for any of the foundational lines of humanized immune system animal models, with a focus on their use in studying combinatorial treatment strategies.
Part II
The second session in this series expands into the cutting-edge possibilities supported by models endogenously expressing human cytokines.
About The Presenter
Paul Volden, PhD
Field Applications Scientist | Taconic Biosciences
Dr. Paul Volden is a Field Application Scientist at Taconic Biosciences. He earned his PhD from the University of Chicago’s Committee on Molecular Metabolism and Nutrition and has over a decade of biological and biomedical research experience, spanning rodent model applications for cancer, metabolic disease, and cardiovascular disease.
At Taconic, Dr. Volden assists researchers with in vivo model selection and study design, specializing in humanized immune system mice as preclinical models for evaluating novel immunotherapies.